Verastem, Inc.
Verastem, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Available For Sale Securities Debt Securities Curr… | - | - | - | - | - | - | - | - | - | 29 | 59 | 71 | |||||
Cash And Cash Equivalents At Carrying Value | 136 | 166 | 205 | 138 | 164 | 118 | 89 | 113 | 83 | 81 | 78 | 95 | |||||
Short Term Investments | - | 16 | - | - | - | - | - | - | - | - | - | - | |||||
Accounts Receivable Net | 29 | 10 | 9 | 7 | 2 | - | - | - | 10 | - | - | - | |||||
Inventory Net | 2 | 2 | 2 | 2 | 1 | - | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 8 | 9 | 8 | 8 | 7 | 7 | 6 | 7 | 5 | 7 | 7 | 9 | |||||
Assets Current | 176 | 203 | 223 | 154 | 174 | 125 | 95 | 121 | 100 | 118 | 144 | 174 | |||||
Property Plant And Equipment Net | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 3 | 3 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Restricted Cash And Cash Equivalents Noncurrent | 0 | 0 | - | - | - | 0 | 0 | - | 0 | 0 | 0 | 0 | |||||
Finite Lived Intangible Assets Net | 16 | 16 | 16 | 17 | 16 | - | - | - | - | - | - | - | |||||
Other Assets Noncurrent | 12 | 6 | 6 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 5 | 0 | |||||
Assets | 207 | 228 | 246 | 177 | 196 | 132 | 102 | 126 | 106 | 124 | 150 | 176 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 18 | 10 | 12 | 10 | 8 | 7 | 4 | 4 | 7 | 7 | 7 | 5 | |||||
Accrued Liabilities Current | 54 | 51 | 54 | 45 | 38 | 25 | 26 | 22 | 17 | 17 | 18 | 16 | |||||
Deferred Revenue Current | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Notes Payable Current | 0 | 1 | - | 0 | 0 | 1 | - | 0 | 1 | 1 | - | 0 | |||||
Supplier Finance Program Obligation Current | - | 5 | 5 | - | - | - | - | - | - | - | - | - | |||||
Operating Lease Liability Current | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Secured Debt Current | - | - | - | - | - | - | - | 10 | 5 | - | - | - | |||||
Liabilities Current | 78 | 67 | 72 | 60 | 50 | 36 | 31 | 37 | 30 | 27 | 26 | 24 | |||||
Liabilities Noncurrent | |||||||||||||||||
Other Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Secured Long Term Debt | 74 | 73 | 76 | 78 | 74 | 71 | 41 | 31 | 35 | 40 | 40 | 40 | |||||
Supplier Finance Program Obligation Noncurrent | - | 4 | 5 | - | - | - | - | - | - | - | - | - | |||||
Warrants And Rights Outstanding | - | - | 36 | 48 | 22 | 55 | 58 | 26 | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 2 | 2 | - | - | - | 0 | 1 | - | - | 0 | 1 | 1 | |||||
Liabilities | 157 | 146 | 189 | 192 | 160 | 164 | 130 | 94 | 66 | 77 | 71 | 72 | |||||
Convertible Preferred Stock Nonredeemable Or Redee… | - | - | - | - | - | - | - | 21 | 21 | - | 21 | - | |||||
Stockholders Equity | |||||||||||||||||
Accounts Payable And Accrued Liabilities Noncurren… | - | - | - | - | 8 | - | - | - | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Preferred Sto… | |||||||||||||||||
Additional Paid In Capital Common Stock | 1,278 | 1,275 | 1,217 | 1,114 | 1,064 | 969 | 927 | 902 | 886 | 884 | 882 | 881 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 8 | 9 | 5 | 3 | 5 | 7 | - | - | - | -0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -1,236 | -1,202 | -1,165 | -1,132 | -1,034 | -1,008 | -956 | -891 | -867 | -859 | -825 | -798 | |||||
Stockholders Equity | 50 | 82 | 57 | -16 | 36 | -32 | -29 | 11 | 19 | 25 | 57 | 83 | |||||
Liabilities And Stockholders Equity | 207 | 228 | 246 | 177 | 196 | 132 | 102 | 126 | 106 | 124 | 150 | 176 | |||||
Series A Preferred Stock | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 0 | |||||
Series B Preferred Stock | - | - | - | - | - | - | - | - | 1 | 1 | 1 | - | |||||
Seriesa Convertible Preferred Stock | - | - | 0 | 0 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Series B Convertible Preferred Stock | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 10 | 1 | 1 | |||||
Preferred Stock | - | - | 0 | - | - | - | 1 | - | - | - | 4 | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | - | 0 | 0 | 0 | - | 0 | - | - | - | - | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | - | - | - | - | - | - | - | - | - | 1 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | |||||
Common Stock Shares Issued | 90 | 88 | 78 | 67 | 62 | 51 | 45 | 40 | 27 | 25 | 25 | 25 | |||||
Shares Outstanding | 90 | 88 | 78 | 67 | 62 | 51 | 45 | 40 | 27 | 25 | 25 | 25 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -23.50% | -33.22% | 6.89% | - | - | - | - | - | - | - | - | - |
| 2025 | -13.94% | -35.66% | -18.50% | 64.59% | 58.19% | 41.46% | 34.51% | 1.90% | -19.34% | -13.25% | 1.72% | -27.02% |
| 2024 | -66.78% | -75.00% | -75.17% | 11.61% | 20.09% | 41.96% | 37.98% | -4.13% | 52.97% | -31.96% | 5.13% | -5.87% |
| 2023 | - | - | - | -1.69% | -18.94% | -37.99% | -0.85% | 15.13% | 62.94% | 8.95% | 3.81% | -62.29% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.25 | 3.04 | 3.09 | 2.58 | 3.46 | 3.50 | 3.07 | 3.23 | 3.28 | 4.40 | 5.45 | 7.33 | |||||
| Quick Ratio | 2.12 | 2.87 | 2.96 | 2.42 | 3.31 | 3.31 | 2.87 | 3.03 | 3.10 | 4.13 | 5.20 | 6.96 | |||||
| Working Capital | 98.03M | 136.06M | 151.15M | 94.34M | 123.91M | 89.08M | 63.99M | 83.29M | 69.30M | 90.95M | 117.30M | 150.67M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 3.13 | 1.79 | 3.31 | -12.39 | 4.44 | -5.06 | -4.51 | 8.51 | 3.49 | 3.09 | 1.24 | 0.86 | |||||
| Interest Coverage TTM | -108.26 | -128.65 | -149.50 | -85.74 | -58.03 | -36.17 | -25.20 | -25.24 | -21.87 | -22.40 | -22.25 | -20.78 | |||||
| Debt Ratio | 0.76 | 0.64 | 0.77 | 1.09 | 0.82 | 1.25 | 1.28 | 0.75 | 0.62 | 0.63 | 0.48 | 0.41 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.40 | 0.28 | 0.18 | 0.01 | -0.06 | 0.08 | 0.08 | 0.07 | 0.07 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -2.02 | -1.96 | -3.02 | -3.30 | -2.25 | -2.75 | -3.66 | -2.32 | -3.33 | -3.93 | -3.96 | -2.87 | |||||
| Free Cash Flow Per Share TTM | -1.72 | -1.63 | -2.12 | -1.93 | -1.82 | -2.13 | -2.94 | -2.72 | -3.80 | -3.52 | -3.92 | -2.74 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 101.84% | 102.68% | - | - | - | - | - | - | - | - | - | - | |||||
| Operating Profit Margin TTM | -199.51% | -344.56% | -550.33% | -7,498.50% | 1,719.47% | -1,310.71% | -1,149.56% | -1,145.05% | -987.84% | - | - | - | |||||
| Net Profit Margin TTM | -253.07% | -391.16% | -677.59% | -11,282.45% | 1,829.27% | -1,488.77% | -1,306.37% | -934.54% | -894.91% | - | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -979.70% | 395.85% | 209.14% | -78.63% | -191.05% | - | - | - | - | - | -100.00% | -100.00% | |||||
| Net Income Growth (1Y) | 21.70% | 30.28% | 60.35% | 157.99% | 86.11% | 41.09% | 49.53% | 21.67% | 19.49% | 45.41% | 18.36% | 4.52% | |||||
| EPS Growth (1Y) | -19.60% | -28.20% | -17.38% | 41.97% | -24.42% | -30.12% | -7.66% | -19.03% | -21.12% | -9.37% | -13.39% | -35.90% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -1.89 | -2.69 | -2.55 | -2.68 | -1.65 | -2.19 | -1.41 | -1.29 | -0.89 | -3.00 | -2.05 | -2.84 | |||||
| P/B TTM | 7.65 | 6.37 | 9.35 | -41.61 | 7.61 | -10.07 | -6.39 | 10.88 | 4.25 | 12.63 | 3.13 | 2.62 | |||||
| P/S TTM | 4.77 | 10.51 | 17.31 | 302.28 | -30.15 | 32.67 | 18.46 | 12.04 | 8.00 | - | - | - | |||||
| Market Cap | 382.44M | 520.95M | 535.07M | 645.98M | 274.49M | 326.66M | 184.64M | 120.37M | 80.05M | 316.62M | 179.52M | 217.80M | |||||
| Enterprise Value | 319.84M | 428.80M | 406.16M | 586.34M | 184.67M | 281.07M | 136.30M | 47.61M | 37.28M | 275.06M | 140.53M | 161.09M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -171.82M | -160.57M | -147.13M | -140.93M | -120.26M | -115.18M | -104.83M | -109.41M | -102.18M | -94.50M | -86.46M | -73.40M | |||||
| Net Debt | -62.61M | -92.14M | -128.90M | -59.64M | -89.82M | -45.59M | -48.34M | -72.77M | -42.77M | -41.56M | -38.99M | -56.71M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Verastem, Inc. (VSTM) — SEC Financial Statements & Analysis
Verastem, Inc. (VSTM) is a pharmaceutical preparations company, incorporated in MA. Verastem, Inc. trades on Nasdaq as: VSTM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Verastem, Inc. reported a -979.70% year-over-year revenue growth, a Gross Profit Margin of 101.84% (TTM), a Debt-to-Equity ratio of 3.13x, a Price-to-Sales (P/S) ratio of 4.77x (TTM), a Price-to-Book (P/B) ratio of 7.65x (TTM), at a market cap of $382.44M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -979.70%
- Gross Profit Margin TTM
- 101.84%
- Debt To Equity
- 3.13x
- P/S TTM
- 4.77x
- P/B TTM
- 7.65x
- Market Cap
- $382.44M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Verastem, Inc. in?
Verastem, Inc. (VSTM) operates in the Pharmaceutical Preparations industry.
What is VSTM's market cap?
Verastem, Inc. (VSTM) has a market capitalization of $382.44M as of 2026-06-30.
What exchange does VSTM trade on?
Verastem, Inc. (VSTM) trades on the Nasdaq.
Where is Verastem, Inc. incorporated?
Verastem, Inc. is incorporated in MA.